Volume 121, Issue 6 , Pages 1448-1454, June 2008
The acquisition of tolerance toward cow's milk through probiotic supplementation: A randomized, controlled trial
Background
Cow's milk allergy (CMA) is the most frequently diagnosed food allergy in infancy. In general, patients have a good prognosis because the majority acquire tolerance within the first years. Interventions have been proposed to accelerate tolerance and reduce morbidity. Probiotic supplementation could be effective through modulation of the immune system.
Objective
We sought to determine whether supplementation with a combination of probiotics (Lactobacillus casei CRL431 and Bifidobacterium lactis Bb-12) accelerates tolerance to cow's milk (CM) in infants with CMA.
Methods
We performed a double-blind, randomized, placebo-controlled trial in 119 infants with CMA. Infants received CRL431 and Bb-12 supplemented to their standard treatment of extensively hydrolyzed formula for 12 months. Primary outcome was clinical tolerance to CM at 6 and 12 months of treatment. Furthermore, we analyzed T- and B-lymphocyte subsets (CD3+, CD3+CD4+, CD3+CD8+, and CD20+) in peripheral blood at randomization and at 12 months with flow cytometry and examined the presence of viable probiotic strains in fecal samples.
Results
The cumulative percentage of tolerance to CM at 6 and 12 months was similar in both groups: 56 (77%) in the probiotics group versus 54 (81%) in the placebo group. Infants in the placebo group had higher percentages of CD3+ and CD3+CD4+ lymphocytes compared with those seen in probiotic-treated infants. Probiotic intake was confirmed because probiotics were isolated from feces more often in treated infants than in the placebo group.
Conclusion
Supplementation of CRL431 and Bb-12 to extensively hydrolyzed formula does not accelerate CM tolerance in infants with CMA.
Key words: Cow's milk allergy, probiotics, tolerance, infants, atopic eczema/dermatitis syndrome, flow cytometry
Abbreviations used: AEDS, Atopic eczema/dermatitis syndrome, CAMEL, Cow's Milk Allergy Modified by Elimination and Lactobacilli, CMA, Cow's milk allergy, CM, Cow's milk, DBPCFC, Double-blind, placebo-controlled food challenge, OR, Odds ratio, SPT, Skin prick test
The Cow's Milk Allergy Modified by Elimination and Lactobacilli project was an investigator-initiated trial that was funded by the Dutch Government (Ministry of Economic Affairs: Senter) (see the Appendix for a list of study group members). Royal Friesland Foods (RFF) were invited to participate as providers of the extensively hydrolyzed formula and the probiotics. Funding for this part of our studies was provided by RFF.
Disclosure of potential conflict of interest: L. F. de Ruiter and J. Hol have received research support from the Dutch Ministry of Economic Affairs. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(08)00602-7
doi:10.1016/j.jaci.2008.03.018
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 121, Issue 6 , Pages 1448-1454, June 2008
